CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to ARVN

Vepdegestrant (ARV-471/PF-07850327)

Phase 3
Arvinas, Inc. (ARVN)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Dec '26
ARVNPhase 3

Vepdegestrant (ARV-471/PF-07850327) Phase 3 Est. Readout (VERITAC-3)

Vepdegestrant (ARV-471/PF-07850327)
Dec 2026~
CT.gov
00%
Drug Information

Target Indication

Breast Cancer

Clinical Trial

NCT05909397

Last updated: 10/21/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.